Bellantone Rocco, Lombardi Celestino Pio, Raffaelli Marco, Boscherini Mauro, Alesina Pier Francesco, De Crea Carmela, Traini Emanuela, Princi Pietro
Division of Endocrine Surgery, Department of Surgery, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy.
Surgery. 2002 Dec;132(6):1109-12; discussion 1112-3. doi: 10.1067/msy.2002.128617.
Our goal was to determine whether routine oral calcium (OC) and vitamin D (VD) administration can effectively prevent symptoms of hypocalcemia after total thyroidectomy.
Seventy-nine patients who underwent total thyroidectomy were randomly allotted to one of the following groups: (1) group A, no treatment; (2) group B, OC 3 g per day; (3) group C, OC 3 g + VD 1 mg per day. Treatment was started on postoperative (PO) day 1 in groups B and C.
Fewer patients in groups B and C experienced symptoms when compared with group A (P =.005). Patients in groups B and C had only minor symptoms, whereas 2 patients in group A experienced major symptoms and 6 required intravenous calcium (P <.01). The rate of hypocalcemia was slightly lower in group C (P = not significant). Treatment was discontinued by PO day 7 in all but 8 patients. Two patients still required treatment 6 months after operation (2.5%). PO parathyroid hormone levels did not differ in the 3 groups (P = not significant).
Routine supplementation therapy with OC or VD effectively prevents symptomatic hypocalcemia after total thyroidectomy and may allow for a safe early discharge. Further studies are necessary to determine the best treatment. The combination of OC and VD may further reduce the rate of PO hypocalcemia, without inhibiting parathyroid hormone secretion.
我们的目标是确定常规口服钙剂(OC)和维生素D(VD)给药能否有效预防全甲状腺切除术后的低钙血症症状。
79例行全甲状腺切除术的患者被随机分配至以下组之一:(1)A组,不治疗;(2)B组,每日口服OC 3g;(3)C组,每日口服OC 3g + VD 1mg。B组和C组于术后(PO)第1天开始治疗。
与A组相比,B组和C组出现症状的患者较少(P = 0.005)。B组和C组患者仅有轻微症状,而A组有2例患者出现严重症状,6例需要静脉补钙(P < 0.01)。C组低钙血症发生率略低(P = 无显著性差异)。除8例患者外,所有患者均在PO第7天停止治疗。2例患者术后6个月仍需治疗(2.5%)。3组患者的PO甲状旁腺激素水平无差异(P = 无显著性差异)。
常规补充OC或VD可有效预防全甲状腺切除术后的症状性低钙血症,并可能实现安全早期出院。需要进一步研究以确定最佳治疗方法。OC和VD联合使用可能进一步降低PO低钙血症的发生率,而不抑制甲状旁腺激素分泌。